Foundation models and AI operating system for small molecule drug discovery
Drug discovery teams struggle to efficiently design and optimize small molecule candidates due to slow, expensive, and iterative R&D processes.
It provides foundation models and an AI operating system that generate and optimize small molecule designs to accelerate drug discovery workflows.
Pharma companies, biotech firms, and medicinal chemistry/drug discovery teams developing small molecule therapeutics.




